Stock OXIS INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Oxis International Euronext Paris

Equities

US6918294025

End-of-day quote Euronext Paris
Other stock markets
- EUR - Intraday chart for Oxis International
06-27 GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 MT
06-27 GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study DJ

Chart calendar Oxis International

0d90a664827fbbc6598f7ee3.V7xUOHi90x15OPZ90evBEhttHERY9XUzxrJC4bYBHg0.INMtCgn6gV9Ob7lKpKOzRCg1JHIApDx7sMoKr_1IXU4S-SxvLMu5Rw9htw~45fb93239f5bff4a8d88b1cbab3b4f6d

Upcoming events on Oxis International

06/08/2024 Q2 2024 Earnings Release (Projected)
28/10/2024 Q3 2024 Earnings Release (Projected)
18/05/2025 Q1 2025 Earnings Release (Projected)
17/05/2026 Q1 2026 Earnings Release (Projected)

Past events on Oxis International

25/06/2024 19:00 Annual General Meeting
15/05/2024 22:00 Q1 2024 Earnings Release
18/12/2023 19:00 Extraordinary Shareholders Meeting
05/11/2023 02:00 Society for Immunotherapy of Cancer Meeting - Abstract No:1180
04/11/2023 18:55 Society for Immunotherapy of Cancer Meeting - Abstract No:1180
01/11/2023 13:00 Q3 2023 Earnings Release
17/08/2023 20:30 H.C. Wainwright Immune Cell Engager Conference
07/08/2023 14:00 Q2 2023 Earnings Release
28/06/2023 19:00 Annual General Meeting
24/05/2023 ASTCT EBMT Joint Basic and Translational Scientific Meeting
16/05/2023 14:00 PEGS Boston Conference
15/05/2023 22:00 Q1 2023 Earnings Release
30/03/2023 22:00 Q4 2022 Earnings Release
28/02/2023 14:00 H.C. Wainwright Cell Therapy Virtual Conference
12/12/2022 23:00 American Society of Hematology Meeting - Abstract Number: 4623
11/11/2022 14:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204
11/11/2022 14:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202
31/10/2022 21:15 Q3 2022 Earnings Release
27/10/2022 00:30 LD Micro Main Event Conference
10/10/2022 19:00 Extraordinary Shareholders Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		0,00


-6,76
-6,10
-10.89%		-57,5
-46,2
-24.59%		-21,3
-21,2
-0.2%		-13,6
-13,9
2.65%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-28,3
-16,9
-67.12%		-58,0
-46,6
-24.61%		-20,9
-21,5
2.87%		-7,60
-8,17
7.04%
Net income
Million USD		Released
Forecast
Spread 		-38,6


-28,3
-16,9
-67.12%		-58,0
-46,3
-25.2%		-20,9
-21,5
3%		-7,60
-8,17
7.04%
EPS
USD		Released
Forecast
Spread 		-342


-194
-6,75
-2766.67%		-61,8
-49,4
-25.1%		-19,8
-20,1
1.49%		-5,64
-6,00
6%
Announcement Date27/03/2016/04/2128/03/2230/03/2326/03/24

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-5,44
-7,45
26.95%		-3,01
-5,96
49.4%		-7,02
-3,83
-83.15%		-5,78
-5,73
-0.93%		-3,67
-5,70
35.7%		-3,62
-4,15
12.75%		-3,12
-3,95
20.96%		-3,17
-3,54
10.43%		-3,09
-3,88
20.38%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%		-2,27
-3,88
41.63%
Net income
Million USD		Released
Forecast
Spread 		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%		-2,27
-3,88
41.63%
EPS
USD		Released
Forecast
Spread 		-5,10
-6,90
26.09%		-3,00
-5,40
44.44%		-6,60
-3,30
-100%		-5,40
-5,70
5.26%		-0,30
-4,80
93.75%		-1,50
-3,00
50%		-1,80
-3,00
40%		-5,52
-2,70
-104.44%		-1,64
-2,70
39.26%
Announcement Date16/05/2215/08/2231/10/2230/03/2315/05/2307/08/2301/11/2326/03/2415/05/24

Upcoming sector events for Oxis International

17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
18/07/2024 TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 INNOVIVA, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2024 Earnings Release
23/07/2024 LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2024 Earnings Release (Projected)
23/07/2024 IPSEN: Q2 2024 Earnings Release
More events

Past sector events for Oxis International

Today 11:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
Today GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
09/07/2024 LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release
09/07/2024 12:35 SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release
03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
02/07/2024 10:05 ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release
21/06/2024 16:28 DEVA HOLDING: Q1 2024 Earnings Release
13/06/2024 22:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. GTBP Stock
  4. Stock
  5. Calendar Oxis International